EirGenix (ROCO:6589) Short-Term Capital Lease Obligation : NT$23.2 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is EirGenix Short-Term Capital Lease Obligation?

EirGenix's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was NT$23.2 Mil.

EirGenix's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 (NT$28.7 Mil) to Dec. 2024 (NT$27.9 Mil) and declined from Dec. 2024 (NT$27.9 Mil) to Mar. 2025 (NT$23.2 Mil).

EirGenix's annual Short-Term Capital Lease Obligation increased from Dec. 2022 (NT$26.8 Mil) to Dec. 2023 (NT$28.6 Mil) but then declined from Dec. 2023 (NT$28.6 Mil) to Dec. 2024 (NT$27.9 Mil).

EirGenix Short-Term Capital Lease Obligation Historical Data

The historical data trend for EirGenix's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EirGenix Short-Term Capital Lease Obligation Chart

EirGenix Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

18.77

19.23

26.83

28.62

27.91

EirGenix Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															29.80	29.67	28.66	27.91	23.25

EirGenix Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

EirGenix Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of EirGenix's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

EirGenix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180

Website

https://www.eirgenix.com

EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Furthermore, the company has two PIC/S GMP facilities, one for mammalian cells and one for microbial, to provide clinical trial drug and commercial drug production. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST.

EirGenix Headlines

No Headlines